Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1129928 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $0.79Day −1.00%Mkt cap $95M1Y −27.3%Off 52W high −47.5%Vol (1Y) 88.8%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,047 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest6.7% of sh out |
| Days to cover4.2d |
| 13F net flow (QoQ)+0.37% |
| Top-10 13F concentration74.7% |
| Next report (est.)2026-08-12 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$28.8M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−9.0% |
| 1Y−27.3% |
| 3Y−71.8% |
| 5Y−67.0% |
| Since incept. (ann.)−22.1% |
Total return through 2026-07-28 · series begins 2018-05-31. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)88.8% |
| Ann. volatility (3Y)83.2% |
| Sharpe (1Y)0.06 |
| Sharpe (3Y)−0.11 |
| Max drawdown (1Y)−45.4% |
| Max drawdown (3Y)−88.2% |
| Beta (3Y vs SPY)1.14 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| MARSHALL WACE, LLP | 859,831 | $730,859 | 0.72% | +228.0% |
| RENAISSANCE TECHNOLOGIES LLC | 715,838 | $607,603 | 0.60% | new |
| Sandbox Financial Partners, LLC | 400,000 | $339,520 | 0.34% | new |
| SEEDS INVESTOR LLC | 258,306 | $263,472 | 0.22% | +0.0% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 149,000 | $126,471 | 0.12% | +106.9% |
| Everhart Financial Group, Inc. | 138,161 | $117,271 | 0.12% | new |
| XTX Topco Ltd | 109,758 | $93,163 | 0.09% | +39.5% |
| DOLIVER ADVISORS, LP | 100,000 | $84,880 | 0.08% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | −$0.08 | — | — | — |
| 2025-03-31 | — | −$0.06 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-12 is ESTIMATED from filing cadence (median gap 45d) — not company-confirmed.
